Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,422 | -143,099 | -165,291 | -124,088 | -196,273 |
| Depreciation Amortization | 4,205 | -2,754 | 608 | 3,129 | 10,462 |
| Accounts receivable | -3,804 | 20,124 | -5,084 | -9,616 | -5,019 |
| Accounts payable and accrued liabilities | 1,984 | 350 | 1,170 | -2,847 | 3,465 |
| Other Working Capital | -302 | 31,421 | -19,989 | -23,189 | 1,170 |
| Other Operating Activity | -53,147 | 1,235 | 39,032 | 49,495 | 25,961 |
| Operating Cash Flow | $-127,486 | $-92,723 | $-149,554 | $-107,116 | $-160,234 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -142 | N/A | -118 | -212 | -145 |
| Purchase Of Investment | -58,822 | -159,151 | -226,016 | -45,228 | -274,577 |
| Sale Of Investment | 154,437 | 167,091 | 121,878 | 192,780 | 221,037 |
| Other Investing Activity | 0 | 0 | 0 | -5,500 | 0 |
| Investing Cash Flow | $95,473 | $7,940 | $-104,256 | $141,840 | $-53,685 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 83,300 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,452 | 1,124 | 193,738 | 13,648 | 172,083 |
| Other Financing Activity | -43,106 | 0 | 0 | 60,000 | 0 |
| Financing Cash Flow | $41,646 | $1,124 | $193,738 | $73,648 | $172,083 |
| Exchange Rate Effect | -11 | -34 | -488 | -48 | 268 |
| Beginning Cash Position | 53,192 | 136,885 | 197,445 | 89,121 | 130,689 |
| End Cash Position | 62,814 | 53,192 | 136,885 | 197,445 | 89,121 |
| Net Cash Flow | $9,622 | $-83,693 | $-60,560 | $108,324 | $-41,568 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,486 | -92,723 | -149,554 | -107,116 | -160,234 |
| Capital Expenditure | -142 | N/A | -118 | -212 | -145 |
| Free Cash Flow | -127,628 | -92,723 | -149,672 | -107,328 | -160,379 |